Dear Doctor Letter (Rote-Hand-Brief) on Imnovid® (pomalidomide): Hepatitis B virus status to be clarified prior to beginning treatment
2016.04.25
Active substance: pomalidomide
The company Celgene is circulating information that in rare cases a hepatitis B re-activation occurred in patients who received pomalidomide in combination with dexamethasone and had previously become infected with the hepatitis B virus (HBV).
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN